Drug Profile
Levetiracetam - HQ Specialty Pharma
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator HQ Specialty Pharma
- Class Acetamides; Antidementias; Antiepileptic drugs; Neuroprotectants; Nootropics; Pyrrolidinones; Small molecules
- Mechanism of Action SV2A protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Myoclonic epilepsies; Seizures; Tonic-clonic epilepsy